Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 유충규 | - |
dc.date.accessioned | 2016-08-28T11:08:33Z | - |
dc.date.available | 2016-08-28T11:08:33Z | - |
dc.date.issued | 1997 | - |
dc.identifier.issn | 0006-2952 | - |
dc.identifier.other | OAK-12496 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/228634 | - |
dc.description.abstract | The effects of 2-[(4-acetylphenyl)amino]-3-chloro-1,4-napthalenedione (NQ-Y15), a synthetic 1,4-naphthoquinone derivative, on platelet activity and its mechanism of action were investigated. NQ-Y15 caused a concentration-dependent inhibition of the aggregation induced by thrombin, collagen, arachidonic acid (AA), and A23187. The IC50 values of NQ-Y15 on thrombin (0.1 U/mL)-, collagen (10 μg/mL)-, AA (50 μM)-, and A23187 (2 μM)-induced aggregation were 36.2 ± 1.5, 6.7 ± 0.7, 35.4 ± 1.7, and 93.1 ± 1.4 μM, respectively. NQ-Y15 also inhibited thrombin-, collagen-, AA-, and A23187-stimulated serotonin secretion in a concentration dependent manner. However, a high concentration (100 μM) of NQ-Y15 showed no significant inhibitory effect on ADP-induced primary aggregation, which is independent of thromboxane A2 (TXA2) production in rat platelets. In fura-2-loaded platelets, the elevation of intracellular free calcium concentration stimulated by AA, thrombin, and 4-bromo-A23187 was inhibited by NQ-Y15 in a concentration-dependent manner. The formation of TXA2 caused by AA, thrombin, and collagen was inhibited significantly by NQ-Y15. NQ-Y15 inhibited TXA2 synthase in intact rat platelets, since this agent reduced the conversion of prostaglandin (PG) H2 to TXA2. Similarly, NQ-Y15 selectively inhibited the TXA2 synthase activity in human platelet microsomes, whereas it had no effect on activity of phospholipase A2, cyclooxygenase, and PGI2 synthase in vitro. NQ-Y15 inhibited platelet aggregation induced by the endoperoxide analogue U46619 in human platelets, indicating TXA2 receptor antagonism, possibly of a competitive nature. These results suggest that the antiplatelet effect of NQ-Y15 is due to a combination of TXA2 synthase inhibition with TXA2 receptor blockade, and that it may be useful as an antithrombotic agent. | - |
dc.language | English | - |
dc.title | Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets | - |
dc.type | Article | - |
dc.relation.issue | 2 | - |
dc.relation.volume | 54 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.startpage | 259 | - |
dc.relation.lastpage | 268 | - |
dc.relation.journaltitle | Biochemical Pharmacology | - |
dc.identifier.doi | 10.1016/S0006-2952(97)00179-2 | - |
dc.identifier.scopusid | 2-s2.0-0030611418 | - |
dc.author.google | Chang T.-S. | - |
dc.author.google | Kim H.-M. | - |
dc.author.google | Lee K.-S. | - |
dc.author.google | Khil L.-Y. | - |
dc.author.google | Mar W.-C. | - |
dc.author.google | Ryu C.-K. | - |
dc.author.google | Moon C.-K. | - |
dc.contributor.scopusid | 유충규(15846918400) | - |
dc.date.modifydate | 20180104081001 | - |